| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Camrelizumab plus famitinib in previously chemo-immunotherapy treated patients with advanced NSCLC: results from an open-label multicenter phase 2 basket study
|
Ren, Shengxiang
|
|
|
73 |
7 |
|
artikel
|
| 2 |
Chemoradiotherapy versus surgery after neoadjuvant chemoimmunotherapy in patients with stage III NSCLC: a real-world multicenter retrospective study
|
Guan, Song
|
|
|
73 |
7 |
|
artikel
|
| 3 |
circATAD2 mitigates CD8+ T cells antitumor immune surveillance in breast cancer via IGF2BP3/m6A/PD-L1 manner
|
Zhang, Zhiling
|
|
|
73 |
7 |
|
artikel
|
| 4 |
Clinical outcomes of adjuvant nivolumab in resected stage III melanoma: comparison of CheckMate 238 trial and real-world data
|
Moser, Justin C.
|
|
|
73 |
7 |
|
artikel
|
| 5 |
Codonopsis pilosula-derived glycopeptide dCP1 promotes the polarization of tumor-associated macrophage from M2-like to M1 phenotype
|
Liu, Hongxu
|
|
|
73 |
7 |
|
artikel
|
| 6 |
Dual roles of HK3 in regulating the network between tumor cells and tumor-associated macrophages in neuroblastoma
|
Wu, Xin
|
|
|
73 |
7 |
|
artikel
|
| 7 |
Effect of radiochemotherapy on peripheral immune response in glioblastoma
|
Hampe, Léa
|
|
|
73 |
7 |
|
artikel
|
| 8 |
Efficacy and safety of surufatinib plus toripalimab, a chemotherapy-free regimen, in patients with advanced gastric/gastroesophageal junction adenocarcinoma, esophageal squamous cell carcinoma, or biliary tract cancer
|
Zhang, Panpan
|
|
|
73 |
7 |
|
artikel
|
| 9 |
Epigenetic silencing of LDHB promotes hepatocellular carcinoma by remodeling the tumor microenvironment
|
Zhang, Peng
|
|
|
73 |
7 |
|
artikel
|
| 10 |
Evaluation of the antitumor effect of neoantigen peptide vaccines derived from the translatome of lung cancer
|
Lian, Fenbao
|
|
|
73 |
7 |
|
artikel
|
| 11 |
GGT5: a potential immunotherapy response inhibitor in gastric cancer by modulating GSH metabolism and sustaining memory CD8+ T cell infiltration
|
Zhao, Wenjing
|
|
|
73 |
7 |
|
artikel
|
| 12 |
Integrative analysis of single-cell and bulk RNA sequencing unveils a machine learning-based pan-cancer major histocompatibility complex-related signature for predicting immunotherapy efficacy
|
Feng, Jia-Lin
|
|
|
73 |
7 |
|
artikel
|
| 13 |
Long-term survival after anti-PD-1 discontinuation in advanced cutaneous squamous cell carcinoma (cSCC): a proof of concept of benefit of concomitant cemiplimab and radiotherapy
|
Bailly-Caillé, Barbara
|
|
|
73 |
7 |
|
artikel
|
| 14 |
Overexpressing S100A9 ameliorates NK cell dysfunction in estrogen receptor-positive breast cancer
|
Liu, Yansong
|
|
|
73 |
7 |
|
artikel
|
| 15 |
Safety of immune checkpoint inhibitors in patients aged over 80 years: a retrospective cohort study
|
Ikoma, Tatsuki
|
|
|
73 |
7 |
|
artikel
|
| 16 |
Single-cell sequencing of tumour infiltrating T cells efficiently identifies tumour-specific T cell receptors based on the T cell activation score
|
Zhang, Chaoting
|
|
|
73 |
7 |
|
artikel
|
| 17 |
The efficacy and safety of adding PD-1 blockade to induction chemotherapy and concurrent chemoradiotherapy (IC-CCRT) for locoregionally advanced nasopharyngeal carcinoma: an observational, propensity score-matched analysis
|
Jin, Ya-Nan
|
|
|
73 |
7 |
|
artikel
|
| 18 |
The later-line efficacy and safety of immune checkpoint inhibitors plus anlotinib in EGFR-mutant patients with EGFR-TKI-resistant NSCLC: a single-center retrospective study
|
Yin, Xiaoyan
|
|
|
73 |
7 |
|
artikel
|
| 19 |
The lymphocyte/monocyte ratio predicts the efficacy of isatuximab plus pomalidomide in multiple myeloma patients
|
Shimazu, Yutaka
|
|
|
73 |
7 |
|
artikel
|
| 20 |
The optimal threshold of PD-L1 combined positive score to predict the benefit of PD-1 antibody plus chemotherapy for patients with HER2-negative gastric adenocarcinoma: a meta-analysis
|
Li, Ji-Bin
|
|
|
73 |
7 |
|
artikel
|
Tijdschrift beschrijving